C4 Therapeutics, Inc. · NASDAQ:CCCC

Orbimed Advisors LLC reported a 5.00% stake in C4 Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Orbimed Advisors LLC reported a 5.00% stake in C4 Therapeutics, Inc., 3,568,346 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
5.00%
Shares
3,568,346
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC2.30%1,666,800
OrbiMed Capital LLC5.00%3,568,346

Source

View original at SEC

Related